Background –Prevalence of overt thyroid disease in human immunodeficiency virus (HIV) infected or acquired immunodeficiency syndrome (AIDS) patients is apparently similar to general population. Subclinical hypothyroidism is reportedly more common in HIV/AIDS patients. This issue is being explored in the present study. Aim and Objective -To assess the prevalence of clinical and subclinical thyroid dysfunction in HIV/AIDS patients. Materials and methods –It is a cross sectional study conducted on 150 HIV/AIDS patients. Thyroid function tests (TFT) were analyzed in each of the cases. Results – Thirty two percent patients had thyroid abnormalities. Twenty-eight patients (18.66 %) were diagnosed to have subclinical hypothyroidism. Seventeen patients (11.33%) patients were associated clinical hypothyroidism, two patients (1.33) had subclinical hyperthyroidism and one patient (0.66 ) had clinical hyperthyroidism. Conclusion – Prevalence of subclinical hypothyroidism is higher in HIV/AIDS patients in comparison to general population. Further studies on a larger cohort is needed prior to make any recommendation for screening.
